RecruitingNCT06707441

Thorax vs. Trauma Injury Severity Scores as Outcome Predictors in Chest Trauma

Which Score Best Predicts Outcomes in Chest Trauma? A Prospective Comparison of Thorax and Trauma Injury Severity Scores


Sponsor

Al-Nahrain University

Enrollment

150 participants

Start Date

Jan 20, 2025

Study Type

OBSERVATIONAL

Summary

The goal of this observational study is to compare the predictive utility of the Thorax Trauma Severity Score (TTSS) and the Trauma and Injury Severity Score (TRISS) in determining outcomes among patients presenting with chest trauma to the emergency room. The main questions it aims to answer are: Does the TTSS provide a more accurate prediction of patient outcomes (e.g., mortality, ICU admission) than the TRISS? Are there specific patient subgroups where one score is more effective than the other? Participants will: Have their chest trauma severity assessed using both TTSS and TRISS during their emergency room admission. Have their clinical outcomes (e.g., mortality, ICU admission, length of hospital stay) monitored throughout their hospital stay.


Eligibility

Min Age: 16 Years

Inclusion Criteria3

  • Patients with chest injuries that require clinical assessment using the Thorax Trauma Severity Score (TTSS) and the Trauma Injury Severity Score (TISS) within 6 hours of admission.
  • Patients (or their legal guardians) must provide informed consent for participation in the study. This ensures ethical standards are maintained.
  • Patients presenting with thoracic injuries, including rib fractures, pulmonary contusions, pneumothorax, hemothorax, and other chest-related injuries. This will include both isolated chest trauma and trauma with multiple injuries

Exclusion Criteria6

  • Patients younger than 16 years.
  • Patients with chest injuries caused by conditions unrelated to trauma, such as spontaneous pneumothorax, infections, or other medical conditions (e.g., non-traumatic rib fractures or cancer).
  • Patients with severe co-morbidities (e.g., terminal illnesses, advanced stages of cancer, or end-stage organ failure) that would significantly affect outcomes unrelated to the chest trauma.
  • Patients with pre-existing severe neurological conditions or other comorbidities that would interfere with trauma assessment and clinical management (e.g., severe brain injury, vegetative state).
  • Patients or their legal representatives who refuse consent for participation in the study.
  • Pregnant women due to potential risks associated with trauma and interventions during pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

College of Medicine - Al-Nahrain University

Baghdad, Iraq

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06707441